van Leeuwen Wouter F, Janssen Stein J, ter Meulen Dirk P, Ring David
Department of Orthopaedic Surgery, Hand and Upper Extremity Service, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Yawkey Center, Massachusetts General Hospital, Suite 2100, 55 Fruit Street, Boston, MA, 02114, USA.
Clin Orthop Relat Res. 2016 Mar;474(3):808-13. doi: 10.1007/s11999-015-4541-1. Epub 2015 Sep 1.
Kienböck disease is characterized by osteonecrosis of the lunate. Not all patients with radiographic evidence of the disease experience symptoms bothersome enough to consult a doctor. Little research has been performed on the prevalence of Kienböck disease, and the prevalence in the asymptomatic population is unclear. Knowledge of the natural course of the disease and how often patients are not bothered by the symptoms is important, because it might influence the decision as to whether disease-modifying treatment would be beneficial.
QUESTIONS/PURPOSES: (1) What is the prevalence of incidental and symptomatic Kienböck disease? (2) What are the factors associated with incidental and symptomatic Kienböck disease? (3) Are there differences in Lichtman stage distribution between incidentally discovered and symptomatic Kienböck disease?
We retrospectively searched radiology reports of all MRI scans, CT scans, and radiographs that included the wrists of 51,071 patients obtained over an 11-year period at one institution to screen for Kienböck disease and avascular necrosis of the lunate. Corresponding MR images, CT scans, or radiographs were reviewed by an orthopaedic hand surgeon to confirm the presence of Kienböck disease when the report was inconclusive. The medical record was reviewed to determine whether the radiographic Kienböck disease was incidental. Prevalences were calculated for both symptomatic and incidental Kienböck disease. Additionally, we assessed the association of age, sex, and race with incidental and symptomatic Kienböck disease as well as the radiographic severity according to the Lichtman classification and calculated odds ratios.
We identified 51 cases (0.10%) of incidental Kienböck disease and 87 cases (0.17%) of symptomatic Kienböck disease out of 51,071 patients. Patients with incidental Kienböck were older (mean, 54 years; SD, 17; mean difference, -6.1; 95% confidence interval [CI], -11 to -0.96; p = 0.020) and patients with symptomatic Kienböck disease were younger (mean, 43 years; SD, 14; mean difference, 5.1; 95% CI, 1.2-9.0; p = 0.010) compared with the group of patients without Kienböck disease (mean, 48 years; SD, 19). Lunate collapse (Lichtman Stages III and IV) was seen in nine of 51 patients (18%) with incidental Kienböck disease and in 44 of 87 patients (51%) with symptomatic Kienböck disease (odds ratio, 0.21; 95% CI, 0.086-0.51; p < 0.001). Our study did not identify any other factors associated with Kienböck disease.
We found that Kienböck disease is diagnosed on radiographs in a notable number of asymptomatic patients and that asymptomatic patients are more likely to have precollapse stages of the disease. This suggests that symptoms and disability do not correlate with pathophysiology, progression, or activity. Patients and surgeons benefit from awareness that symptoms are not a good indicator of the severity or prognosis of pathophysiology and that lunate osteonecrosis can exist with no or insufficient symptoms. This is important when considering treatment, because we cannot distinguish active disease at risk of collapse that could merit disease-modifying treatment from disease that will not progress.
Level III, prognostic study.
月骨缺血性坏死病的特征是月骨出现骨坏死。并非所有有该疾病影像学证据的患者都会出现严重到需要就医的症状。关于月骨缺血性坏死病的患病率研究较少,无症状人群中的患病率尚不清楚。了解该疾病的自然病程以及患者未受症状困扰的频率很重要,因为这可能会影响是否进行改善病情治疗有益的决策。
问题/目的:(1)偶然发现的和有症状的月骨缺血性坏死病的患病率是多少?(2)与偶然发现的和有症状的月骨缺血性坏死病相关的因素有哪些?(3)偶然发现的和有症状的月骨缺血性坏死病在Lichtman分期分布上是否存在差异?
我们回顾性检索了一家机构在11年期间获取的51071例患者的所有MRI扫描、CT扫描和X线片报告,这些报告包含手腕部位,以筛查月骨缺血性坏死病和月骨缺血性坏死。当报告不明确时,由一名骨科手外科医生复查相应的MR图像、CT扫描或X线片,以确认月骨缺血性坏死病的存在。查阅病历以确定影像学上的月骨缺血性坏死病是否为偶然发现。计算有症状和偶然发现的月骨缺血性坏死病的患病率。此外,我们评估了年龄、性别和种族与偶然发现的和有症状的月骨缺血性坏死病的关联,以及根据Lichtman分类法的影像学严重程度,并计算优势比。
在51071例患者中,我们发现了51例(0.10%)偶然发现的月骨缺血性坏死病和87例(0.17%)有症状的月骨缺血性坏死病。与无月骨缺血性坏死病的患者组(平均年龄48岁;标准差19)相比,偶然发现月骨缺血性坏死病的患者年龄较大(平均54岁;标准差17;平均差异 -6.1;95%置信区间[CI],-11至-0.96;p = 0.020),有症状的月骨缺血性坏死病患者年龄较小(平均43岁;标准差14;平均差异5.1;95%CI,1.2 - 9.0;p = 0.010)。51例偶然发现月骨缺血性坏死病的患者中有9例(18%)出现月骨塌陷(Lichtman III期和IV期),87例有症状的月骨缺血性坏死病患者中有44例(51%)出现月骨塌陷(优势比,0.21;95%CI,0.086 - 0.51;p < 0.001)。我们的研究未发现与月骨缺血性坏死病相关的任何其他因素。
我们发现,在大量无症状患者的X线片上可诊断出月骨缺血性坏死病,且无症状患者更可能处于疾病的塌陷前期。这表明症状和残疾与病理生理、进展或活动情况无关。患者和外科医生应认识到,症状并非病理生理严重程度或预后的良好指标,月骨缺血性坏死可能在没有症状或症状不明显的情况下存在。在考虑治疗时这很重要,因为我们无法区分有塌陷风险的活动性疾病(可能值得进行改善病情治疗)和不会进展的疾病。
III级,预后研究。